Measuring CEA Levels using Cobas e411

The concentration of CEA was determined using a Cobas e411 analyzer (Roche Diagnostics) and a ready-to-use reagent kit (Elecsys CEA; Roche Diagnostics) in individual cassettes according to the manufacturer's protocol. This detection method relies on using electrochemiluminescence to measure the immunoreactivity (20 (link)).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Abid M.N., Qadir F.A, & Salihi A. (2021). Association between the serum concentrations and mutational status of IL-8, IL-27 and VEGF and the expression levels of the hERG potassium channel gene in patients with colorectal cancer. Oncology Letters, 22(3), 665.

Publication 2021

Cobas e411 analyzer Elecsys CEA

Diagnostics

Corresponding Organization :

Other organizations : Salahaddin University-Erbil

Top 5 similar protocols

Variable analysis

independent variables

Not explicitly mentioned

dependent variables

Concentration of CEA

control variables

Cobas e411 analyzer (Roche Diagnostics)
Ready-to-use reagent kit (Elecsys CEA; Roche Diagnostics)
Manufacturer's protocol

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!